Cargando…

Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-β1 and Its Signaling Pathway Molecules

Peritoneal dialysis is one of the main renal replacement treatments. However, long-term peritoneal dialysis keeps the peritoneum in contact with the sugar-containing nonphysiological peritoneal fluid, which leads to recurrent peritonitis, peritoneal fibrosis, and failure of ultrafiltration. Transfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Zhiqiang, Yao, Jia, Duan, Nan, Wang, Min, Wang, Shiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421132/ https://www.ncbi.nlm.nih.gov/pubmed/34497655 http://dx.doi.org/10.1155/2021/2052787

Ejemplares similares

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis
por: Lv, Zhi-Dong, et al.
Publicado: (2023)

Sulodexide in IgA nephropathy
Publicado: (2013)

Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
por: Song, Ji Hun, et al.
Publicado: (2014)

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
por: Huang, Qian, et al.
Publicado: (2022)

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Andreozzi, Giuseppe M., et al.
Publicado: (2015)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016)

Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway
por: Liu, Kang-Han, et al.
Publicado: (2019)

Use of sulodexide in patients with peripheral vascular disease
por: Lasierra-Cirujeda, J, et al.
Publicado: (2010)

Sulodexide in the Treatment of Early Stages of COVID-19
por: Gonzalez-Ochoa, Alejandro, et al.
Publicado: (2021)

Astragaloside Inhibits Hepatic Fibrosis by Modulation of TGF-β1/Smad Signaling Pathway
por: Yuan, Xingxing, et al.
Publicado: (2018)

A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide
por: Song, Chang Hwa, et al.
Publicado: (2020)

TGF-β Pathway in Salivary Gland Fibrosis
por: Zhang, Xianglan, et al.
Publicado: (2020)

Sulodexide pretreatment attenuates renal ischemia-reperfusion injury in rats
por: Yin, Jianyong, et al.
Publicado: (2016)

Sulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
por: Jiang, Qing-Jun, et al.
Publicado: (2018)

Sulodexide Prevents Hyperglycemia-Induced Endothelial Dysfunction and Oxidative Stress in Porcine Retinal Arterioles
por: Dauth, Alice, et al.
Publicado: (2023)

Silica nanoparticles induce liver fibrosis via TGF-β(1)/Smad3 pathway in ICR mice
por: Yu, Yang, et al.
Publicado: (2017)

ST2 blockade mitigates peritoneal fibrosis induced by TGF‐β and high glucose
por: Kim, Yong Chul, et al.
Publicado: (2019)

Up-Regulation of RACK1 by TGF-β1 Promotes Hepatic Fibrosis in Mice
por: Jia, Dongwei, et al.
Publicado: (2013)

Targeting the Notch and TGF-β signaling pathways to prevent retinal fibrosis in vitro and in vivo
por: Fan, Jiawen, et al.
Publicado: (2020)

Anti-Proteinuric Effect of Sulodexide in Immunoglobulin A Nephropathy
por: Bang, Kitae, et al.
Publicado: (2011)

Inhibition of neointimal proliferation of rat carotid artery by sulodexide.
por: Park, H. Y., et al.
Publicado: (1997)

Development and use of sulodexide in vascular diseases: implications for treatment
por: Coccheri, Sergio, et al.
Publicado: (2013)

Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production
por: He, Jia, et al.
Publicado: (2022)

Lysyl Hydroxylase Inhibition by Minoxidil Blocks Collagen Deposition and Prevents Pulmonary Fibrosis via TGF-β(1)/Smad3 Signaling Pathway
por: Shao, Songjun, et al.
Publicado: (2018)

TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
por: Yu, Xiao-Yong, et al.
Publicado: (2022)

Polydatin prevents bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/Smad/ERK signaling pathway
por: Liu, Yan-Lu, et al.
Publicado: (2020)

Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
por: Walton, Kelly L., et al.
Publicado: (2017)

Optimal control of TGF-β to prevent formation of pulmonary fibrosis
por: Bahram Yazdroudi, Fateme, et al.
Publicado: (2022)

Crosstalk between the activated Slit2–Robo1 pathway and TGF‐β1 signalling promotes cardiac fibrosis
por: Liu, Yunqi, et al.
Publicado: (2020)

TGF‐β/Smad and Wnt/β‐catenin signaling pathways are involved in renal fibrosis and its therapies
por: Ying, Jialiang, et al.
Publicado: (2020)

Sulodexide reduces senescence-related changes in human endothelial cells
por: Suminska-Jasinska, Katarzyna, et al.
Publicado: (2011)

Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?
por: Szolnoky, Győző, et al.
Publicado: (2022)

Low Molecular Weight Heparin (LMWH) Improves Peritoneal Function and Inhibits Peritoneal Fibrosis Possibly through Suppression of HIF-1α, VEGF and TGF-β1
por: Li, Juan, et al.
Publicado: (2015)

Sulodexide Develops Contraction in Human Saphenous Vein via Endothelium-Dependent Nitric Oxide Pathway
por: Doganci, Suat, et al.
Publicado: (2023)

Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-β-Induced Epithelial-Mesenchymal Transition
por: Jia, Lining, et al.
Publicado: (2015)

SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-β/Smad3 pathway
por: Guo, Yanhong, et al.
Publicado: (2020)

A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis
por: DiNicolantonio, James J, et al.
Publicado: (2021)

Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
por: Wang, Yinhui, et al.
Publicado: (2021)

Astragalus membranaceus Inhibits Peritoneal Fibrosis via Monocyte Chemoattractant Protein (MCP)-1 and the Transforming Growth Factor-β1 (TGF-β1) Pathway in Rats Submitted to Peritoneal Dialysis
por: Li, Zhenghong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6uqe8fpc4072mb6bioi4lirqc1